Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale
causing emotional, physical, and financial strains on individuals, families, and health care …

Simple Summary In cancer, disseminated neoplastic cells circulating in blood are a source
of tumor DNA, RNA, and protein, which can be harnessed to diagnose, monitor, and better …

Simple Summary Glioblastoma is the most common and malignant primary brain tumor.
Despite intensive research for new treatments, the survival of patients has not significantly …

Simple Summary The field of liquid biopsy is rapidly evolving. Techniques that improve
accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a …

Abstract Background Cell‐free DNA (cfDNA) and cell‐free mitochondrial DNA (cf‐mtDNA)
have been postulated as potential diagnostic and prognostic biomarkers for different human …

Liquid biopsy refers to a set of pathological samples retrieved from non-solid sources, such
as blood, cerebrospinal fluid, urine, and saliva through non-invasive or minimally invasive …

Gliomas, particularly glioblastoma (GBM), represent the most prevalent and aggressive
tumors of the central nervous system (CNS). Despite recent treatment advancements, patient …

At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic
germline genetic variant (hereditary cancer syndrome—HCS). These individuals are …

Diagnosing post-transplant lymphoproliferative disorder (PTLD) is challenging and often
requires invasive procedures. Analyses of cell-free DNA (cfDNA) isolated from plasma is …

Simple Summary Blood-based tests for cancer detection are minimally invasive and could
be useful for screening asymptomatic patients and high-risk populations. Since a single …